Anzeige
Mehr »
Login
Freitag, 25.04.2025 Börsentäglich über 12.000 News von 693 internationalen Medien
Vergiss die Indizes - Forge steigt um 40 %, während der S&P & Dow fällt!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 899376 | ISIN: US5147661046 | Ticker-Symbol: LDE
Frankfurt
25.04.25
08:06 Uhr
5,350 Euro
-0,150
-2,73 %
1-Jahres-Chart
LIFECORE BIOMEDICAL INC Chart 1 Jahr
5-Tage-Chart
LIFECORE BIOMEDICAL INC 5-Tage-Chart
RealtimeGeldBriefZeit
5,4005,55019:53
5,4005,55019:44

Aktuelle News zur LIFECORE BIOMEDICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.04.Lifecore Biomedical, Inc.: Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)54CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) ("Lifecore") a fully integrated contract development and manufacturing organization ("CDMO"), today announced...
► Artikel lesen
14.04.Lifecore Biomedical Taps Thomas Salus as Chief Legal & Administration Officer1
14.04.Lifecore Biomedical, Inc.: Lifecore Biomedical Appoints Thomas D. Salus as Chief Legal and Administration Officer1
LIFECORE BIOMEDICAL Aktie jetzt für 0€ handeln
10.04.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report1
04.04.Lifecore Biomedical targets 12% revenue CAGR and expanded CDMO pipeline by 20271
03.04.LIFECORE BIOMEDICAL, INC. \DE\ - 10-Q, Quarterly Report2
03.04.Lifecore Biomedical GAAP EPS of -$0.47 misses by $0.32, revenue of $35.15M beats by $1.92M1
03.04.Lifecore Biomedical, Inc.: Lifecore Biomedical Reports Third Quarter Fiscal 2025 Financial Results and Provides Corporate Update137-- Recorded Revenues of $35.2 Million for Q3 Fiscal 2025 -- -- Signed Multiple Development Agreements with New and Existing Customers -- -- Strengthened Balance Sheet through Sale of Excess Capital...
► Artikel lesen
03.04.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report2
27.03.Lifecore Biomedical, Inc.: Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 20251
17.03.Humanetics Selects Lifecore Biomedical to Deliver CDMO Services for BIO 3001
17.03.Lifecore Biomedical, Inc.: Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome1
17.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Announces Special Stockholder Meeting2
17.01.LIFECORE BIOMEDICAL, INC. \DE\ - 8-K, Current Report-
07.01.Lifecore Biomedical to sell multi-purpose 10-head isolator filler1
07.01.Lifecore Biomedical Sells Excess Capital Equipment for $17M1
07.01.Lifecore Biomedical, Inc.: Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million176Company Believes it is Well Positioned for Mid-Term and Long-Term Growth asCurrent Capacity Continues to Support up to $300 Million in Annual Revenue CHASKA, Minn., Jan. 07, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
03.01.US Stocks Poised To Open Higher As Futures Advance: Tesla, Bumble, Lifecore Bio In Focus6
02.01.Lifecore Biomedical GAAP EPS of -$0.25 beats by $0.04, revenue of $32.56M beats by $2.81M2
02.01.Lifecore Biomedical Earnings Report: Q2 Overview2
Seite:  Weiter >>
43 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1